Determining the optimum moment of 123-Iodine meta-iodobenzylguanidine (MIBG) myocardial scintigraphy

Determining the optimum moment of 123-Iodine meta-iodobenzylguanidine (MIBG) myocardial scintigraphy - Timing of MIBG myocardial scintigraphy / DOMISC Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36973

Enrollment

Registered

2012-09-03

Start date

2012-10-30

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure Sympathetic myoardial innervation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age 18-75 years old Symptoms of heart failure Able to lie flat on a table for 10 minutes

Exclusion criteria

Exclusion criteria: Severe shortness of breath which makes it impossible for the patient to lie flat for several times under a gamma camera.

Design outcomes

Secondary

Measure	Time frame
Secondary study parameter will be the time savings which can be achieved if the H/M ratio is not significant different between these different scan times.	—

Primary

Measure	Time frame
The main study parameter will be the calculated H/M ratio at 1, 2 ,3 hour p.i. of MIBG compared to the H/M ratio at 4 hours.	—

Countries

Netherlands

Outcome results